Compare RNA & ACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNA | ACH |
|---|---|---|
| Founded | 2012 | 1882 |
| Country | United States | United States |
| Employees | N/A | 6500 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5M | 217.5M |
| IPO Year | 2025 | N/A |
| Metric | RNA | ACH |
|---|---|---|
| Price | $11.54 | $2.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 2 |
| Target Price | ★ $69.26 | $3.38 |
| AVG Volume (30 Days) | 162.8K | ★ 927.0K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $88.12 | N/A |
| Revenue Next Year | $18.11 | $4.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.77 | $1.84 |
| 52 Week High | $73.06 | $4.69 |
| Indicator | RNA | ACH |
|---|---|---|
| Relative Strength Index (RSI) | 28.33 | 38.86 |
| Support Level | N/A | $1.93 |
| Resistance Level | $14.05 | $2.65 |
| Average True Range (ATR) | 0.50 | 0.22 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 0.38 | 5.91 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.